Mesenchymal stem cell-based therapies are promising tools for bone tissue regeneration.
However, tracking cells and maintaining them in the site of injury is difficult. A potential …

Stem cells demonstrate considerable promise for various preclinical and clinical
applications, including drug screening, disease treatments, and regenerative medicine …

The use of tissue engineering to restore and to build new bone tissue is under active
research at present. The following review summarizes the latest studies and clinical trials …

Reconstruction of irregular oral-maxillofacial bone defects with an inflammatory
microenvironment remains a challenge, as chronic local inflammation can largely impair …

Psoralen, one of the active ingredients in Psoralea corylifolia, has been previously reported
to regulate the osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) …

Bone defects have become a major cause of disability and death. To overcome the
limitations of natural bone implants, including donor shortages and immune rejection risks …

Recruiting endogenous stem cells to bone defects without stem cell transplantation and
exogenous factor delivery represents a promising strategy for bone regeneration. Herein, we …

Bone regeneration heavily relies on bone marrow mesenchymal stem cells (BMSCs).
However, recruiting endogenous BMSCs for in situ bone regeneration remains challenging …